|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 701 Pennsylvania Ave., NW Suite 720 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 5632-12
|
||||||||
|
6. House ID# 312570000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Ronald F. Docksai, Ph.D. Vice President Federal Government Relations |
Date | 01/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
HR 1549/S 619 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal disease; (Title II. general provisions in the bill.)
HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 food Safety. Monitoring food safety provisions.)
S. Res 174 Recognizing Kansas and Missouri as the animal health corridor in the U.S. (Support for the resolution.)
HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug date collection.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
S. Res 174 Recognizing Kansas and Missouri as the animal health corridor in the U.S. (Support for Resolution.)
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)
HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HR 3183/S 1436 Energy and Water Development and Related Agencies Appropriations Act; (Provisions relating to funding for a
project evaluating a medical imaging device's ability to generate cost savings to hospitals when used in interventional cardiovascular procedures.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
S 787 A bill to amend the Federal Water Pollution control Act to clarify the jurisdicion of the United States over waters of the United States; (Provisions related to agriculture activities and the section changing the definition of U.S. Waters.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Spurgat |
Ms. |
|
|
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
HR 2868 A bill to amend the Homeland security Act of 2002 to extend, modify, and recodify the authority of the secretary of Homeland Security to enhance security and protect against acts of terrorism against chemical facilities, and for other purposes; (Provisions relating to sensitive security information and citizen action suits.)
HR 2892 A bill making appropriations for the Department of Homeland Security, for the fiscal
year ending September 30, 2010, and for other purposes; (Provisions relating to chemical plant security.)
HR 2996 A bill making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2010, and for other purposes; (Provisions relating to a study by the National Academy of Sciences involving Bayer CropScience's plant in Institute, WV.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S 515 A bill to amend title 35, US Code to provide for patent reform; (sec. 4: Provisions related to the right of the inventor to obtain damages, Sect. 5: Provisons related to Post Grant Procedures, Provisions relating to IPP corporate protection, Provisions relating to apportionment of damages)
HR 1260 Patent Reform Act of 2009; (Provisions relating to apportionment of damages.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
|
Jennifer |
Spurgat |
Ms. |
|
|
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
HR 2454/S 1733 A bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (Provisions relating to agriculture.)
S 1462 American Clean Energy Leadership Act of 2009, a bill to promote clean energy technology development; (All provisions related to enhanced energy efficiency and clean energy development.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
HR 2454 The American Clean Energy and Security Act of 2009 a bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and trasition to a clean energy economy; (All provisiosn pertaining to the advancement of a Cap and Trade greenhouse gas reduction system and energy efficiency measures.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
HR 6228/S 593 the Ban Poisonous Act of 2009 A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act a ban on food contact materials for children and infants (3 years and under); (All provisions
and amendments pertaining to the ban and the testing are relevant.)
HR 4341 Bisphenol-A Consumer Information Act of 2009, a bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.)
HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)
S 510 Food Safety Modernization Act; (Provisions relating to all sections, provisions relating to strategy for comments.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
|
Karen |
Niedermeyer |
Ms |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 6228/S 593 The Ban Poisonous Act of 2009, A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (all provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act a ban on food contact materials for children and infants (3 years and under); (All provisions
and amendments pertaining to the ban and the testing are relevant.)
HR 4341 Bisphenol -A Consumer Information Act of 2009, a bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.)
HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)
HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All provisions relating to follow on biologics.)
S 1142 The "Informed Health Care Decisions Making Act of 2009; (Sections pertaining to comparative effectiveness.)
HR 1321 Healty Americans Act; (Provisions relating to Medicare.)
Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.)
HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provisions relating to healthcare)
HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs, provisions related to subtitles A,B, C and D.)
Senate: Patient Protection & Affordable Care Act; (All provisions relating to health care.)
S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)
S 1679 Affordable Health Choices Act; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)
HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)
HR 1549/S 619 the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisons in the bill.)
HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and cosmetic act to improve the safety of food in the global market, and for other purposes.)
HR 3519/S 1709 Veterinary Services Investment Act (Support for legislation.)
HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug data collection.)
S 510 Food Safety Modernization Act; (Provisions relating to strategy for comments.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms |
|
|
Thomas B. |
Lilburn |
Mr. |
|
|
Julie |
Corcoran |
Ms. |
|
|
Robert D. |
Thomas |
Mr. |
|
|
Donna |
Stephens |
Ms. |
|
|
Ronald F. |
Docksai |
Dr. |
|
|
Karen |
Niedermeyer |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
HR 2892/S 1298 Fiscal 2010 Homeland Security Appropriations, making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2010, and for other purposes; (General provisions of the bill.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
|
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.)
HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs.)
HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
HR 1409/S 560 Employee Free Choice Act; (Provisions related to card check.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MAN
16. Specific lobbying issues
S 515 Patent Reform Act of 2009; (Provisions relating to apportionment of damages.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 1321 Healthy Americans Act; (Provisions relating to Medicare.)
Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.)
HR 3590 Patient Protection and Affordable Care Act; (sections relating to health insurance and drugs.)
HR 3962 Affordable health Care for America Act; (Sections relating to health insurance and drugs.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All relating to follow on biologics.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RRR
16. Specific lobbying issues
S. 146 Railroad Anti-Trust Enforcement Act, a bill to amend the Federal anti-trust laws to provide expanded coverage and to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads; (All provisions pertaining to the "commoncarrier" provisions of the Staggers Act and injuctive relief for exemptions contrary to the public interest.)
S 2889 Surface Transportation Reauthorization Act of 2009, a bill to reauthorize the Surface Transportaion Act and for other
purposes; (All provisions related to bottleneck provisions, common carrier, injunctive relief, rate quotation, competition, and service necessary to business and public interest.)
HR 233 The Railroad Antitrust Enforcement Act of 2009, a bill to amend Federal anti-trust laws to provide expanded coverage and to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads; (all provisions pertaining to the "common carrier" provision of the Staggers Act and injunctive relief for exemptions contrary to the public interest.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
HR 4380 A bill to amend the Harmonized Tariff Scheduled of the United State to modify temporarily certain rates of duty, and for other purposes; (All provisions related to chemicals listed below and a Miscellaneous Tariff Bill to seek introduction of a bill in the Senate (similar to HR 4380) that includes the provisions chemicals listed below:
A bill to suspend temporarily the duty on Olympus WG70
A bill to reduce temporarily the duty on Spirotetramat
A bill to suspend temporarily the duty on Flubendiamide
A bill to reduce temporarily the duty on AE 0172747 Ether
A bill to suspend temporarily the duty on 1,3-Cyclohexanedione.
A bill to extend the temporary suspension of duty on Trichloroacetaldehyde (Chloral)
A bill to extend the temporary suspension of duty on p-chlorobenzaldehyde
A bill to suspend temporarily the duty on mixtures containing 5-Cyclospropyl-4-2(2-Methylsulfonyl-4-Trifluoromethylbenoxyl)Isoxazole (BALANCE PRO)
A bill to suspend temporarily the duty on Isoxaflutole
A bill to extend the reduction of duty on product mixtures containing Iprodione: 3-(3-5,dicholorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide and application adjuvants (ROVRAL)
A bill to extend the temporary suspension of duty on 2-Acetylbutyrolactone
A bill to extend the temporary reduction in duty on Beta-cyfluthrin
A bill to extend the temporary suspension of duty on Cyfluthrin
A bill to temporary suspend the general rate of duty on Clothianidin
A bill to extend the temporary suspension of duty on Ethoprop
A bill to extend the temporary suspension of duty on product mixtures containing Foramsulfuron and Iodosulfuronmethyl-sodium (Equip)
A bill to extend the temporary suspension of duty on Isoxadifen-Ethyl
A bill to extend the temporary reduction of duty on Trifloxystrobin
A bill to extend the temporary suspension of duty on Spiromesifen
A bill to suspend temporarily the duty on Thiencarbazone-methyl
A bill to extend the temporary suspension of duty on FOE Hydroxy
A bill to reduce temporarily the duty on product mixtures containing Tembotrione and application adjuvants ( LAUDIS)
A bill to suspend temporarily the duty on products containing (E)-N-[(2-Chloro-1,3-thiazol-5-yl) methyl]-N-methyl[oxido(oxo)hydrazono] methanediamine or N-[(2-Chloro-1,3-thiazol-5-yl)methyl]-N-{(E)-(methylamino) [oxido(oxo)hydrazono] methyl}amine and application adjucants (PONCHO)
A bill to suspend temporarily the duty on 2(Methylthio)-4-(trifluoromethyl) benzoic acid CAS [142994-05-6]
A bill to suspend temporarily the duty on 2-Chloro-6-(methylthio)toluene (CAS [82961-52-2])
A bill to suspend temporarily the duty on products containing 3-Mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-yl 3,3-dimethylbutyrate and application adjuvants
(OBERON & FORBID)
A bill to suspend temporarily the duty on mixtures containing Pyrasulfotole: 5-Hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone; and Bromoxynil Octanoate: 2,4-Dibromo-6-cyanophenyl octanoate; and Bromoxynil Heptanoate: 2,4-Dibromo-6-cyanophenyl heptanoate (HUSKIE)
A bill to suspend temporarily the duty on 1,3-Dimethyl-1H-pyrazol-5-ol and 1,3-Dimethylpyrazol-5-one (CAS [5203-77-0], [2749-59-9])
A bill to reduce temporarily the duty on product mixtures containing Thiencarbazone-methyl: Methyl 4-({[(3-methoxy-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)carbonyl]amino}sulfonyl)-5-methylthiophene-3-carboxylate and Isoxadifen-ethyl: ethyl 4,5-dihydro-5,5-diphenyl-1,2-oxazole-3-carboxylate and Tembotrione: 2-{2-Chloro-4-mesyl-3-[(trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione and application adjuvants (HTSUS 3808.93.15; CAS: 317815-83-1, 163520-33-0, 335104-84-2) (CAPRENO)
A bill to suspend temporarily the duty on Cyprosulfamide: N-({4-[(Cyclopropylamino) carbonyl]phenyl}sulfonyl)-2-methoxybenzamide (CAS No. Cyprosulfamide: 221667-31-8)
A bill to extend the temporary reduction of duty on ACM
A bill to reduce temporarily the duty on Oxadiazon
A bill to extend the temporary suspension of duty on mixtures of methyl 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] benzoate, sodium salt (Iodosulfuron methyl, sodium salt) and application adjuvants (AUTUMN)
A bill to extend the temporary suspension of duty on Mesosulfuronmethyl
(OSPREY & SILVERADO)
A bill to suspend temporarily the duty on mixtures containing Ethyl(R)-2-[4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy]propionate (Fenoxaprop Ethyl), (CAS No. 71283-80-2), 5-hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone (Pyrafulfotole) (CAS No. 365400-11-9), 2,6-dibromo-4-cyanophenyl octanoate (Bromoxynil octanoate) (CAS No. 1689-99-2), and 2,6-dibromo-4-cyanophenyl heptanoate (Bromoxynil heptanoate) (CAS No. 56634-95-8) (WOLVERINE)
A bill to suspend temporarily the duty on 1,2,4 Triazole
A bill to suspend temporarily the duty on Fluopicolide
A bill to suspend temporarily the duty on Fenhexamid
A bill to suspend temporarily the duty on BELT & SYNAPSE
A bill to extend the temporary suspension of duty on Phenmedipham
A bill to extend the temporary suspension of duty on Propiconazole
A bill to extend the temporary suspension of duty on PREVICUR
A bill to extend the temporary suspension of duty on 2,4-dichloroaniline
A bill to extend the temporary reduction in duty of Aluminum tris (O-ethylphosphonate) whether or not mixed with application adjuvants (FOSETYL-AL)
A bill to suspend temporarily the duty on 2,2-Dimethylbutanoic acid 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro(4.5)dec-3-en-4-yl ester (Spirodiclofen)
A bill to extend the temporary suspension of duty on Fenamidone
A bill to temporarily suspend the duty on cyclopropane-1,1-dicarboxylic acid, dimethyl ester
A bill to suspend temporarily the duty on Pyrasulfotole
A bill to extend the temporary suspension of duty on Pyrimethanil
A bill to reduce temporarily the duty on CORVUS herbicide
A bill to reduce temporarily the duty on EVERGOL
A bill to reduce temporarily the duty on Imidacloprid Pesticides
A bill to suspend temporarily the duty on LIBERTY, RELY and IGNITE herbicides
A bill to reduce the temporarily the duty on Imidacloprid Technical
A bill to extend the temporary suspension of duty on OPTION & REVOLVER
Herbicides
A bill to extend the temporary suspension of duty on 2,6-dibromo-4-cyanophenyl octanoate/heptanoate (Bromoxynil Octanoate / Heptanoate)
A bill to suspend temporarily the product mixtures containing Methyl 2-[({[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl}amino)sulfonyl]-4- [(mesylamino)methyl]benzoate (Mesosulfuron-methyl) and Methyl 4-iodo-2-[3-(4-methoxy -6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl]benzoate, sodium salt (Iodosulfuron-methyl-sodium), whether or not mixed with application adjuvants (HTSUS 3808.93.15; CAS 208465-21-8 144550-36-7)
(ATLANTIS)
A bill to suspend temporarily the duty on certain mixtures containing [3-[(6-chloro-3-pridinyl)methyl]-2-thiazolidinylidene]cyanamide (CALYPSO)
A bill to extend the temporary suspension of duty on Permethrin
A bill to extend the temporary suspension of duty on 2-Chlorobenzyl chloride (O-Chlorobenzylchloride)
A bill to suspend temporarily the duty on product mixtures containing Imidacloprid: 1-(6-Chloro-3-pyridinyl)methyl-N-nitroimidazolidin-2-ylidene amine Z9: (9Z)-9-Tricosene (MAXFORCE WG10 & GR0.5)
A bill to extend the temporary suspension of duty on Resmethrin
A bill to extend the temporary suspension of duty on N-3[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)benzamide (Flutolanil)
A bill to extend the temporary suspension of duty on product mixtures containing 2-(4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-yl)carboxamidosulfonylbenzoate; sodium (4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-ylcarbonyl)(2-methoxycarbonylphenylsulfonyl)azanide & methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-a-(methanesulfonamido)-p-toluate (HTSUS 3808.93.15 AND 9902.24.42; CAS 181274-15-7, 208465-21-8) (RIMFIRE & OLYMPUS FLEX)
To suspend temporarily the duty on Tembotrione
A bill to extend the temporary suspension of duty on Deltamethrin
A bill to suspend temporarily the duty on Hydrazine Hydrate Solution
A bill to extend the temporary reduction of duty on Triadimefon (Bayleton
Technical)
A bill to extend the temporary reduction of duty on Ethofumesate in bulk or mixtures.
A bill to reduce temporarily the duty on product mixtures containing Imidacloprid: 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine and Cyfluthrin:
Cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclo-propanecarboxylate and application adjuvants (HTSUS 3808.91.25; CAS 138261-41-3, 68359-37-5) (LEVERAGE )
A bill to reduce temporarily the duty on product mixtures containing Imidacloprid: 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine and Beta-Cyfluthrin:
(RS)-a-cyano-4-fluro-3-phenoxybenzyl(1RS,3RS;1RS,3SR)-2-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate and application adjuvants (HTSUS 3808.91.25; CAS 138261-41-3, 68359-37-5) (LEVERAGE 360)
A bill to reduce temporarily the duty on Benzamide, N-[2-[3-chloro-5 (trifluoromethyl) 2-pyridinyl]ethyl]-2-(trifluoromethyl) (FLUOPYRAM) whether or not mixed with application adjuvants (FLUOPYRAM)
A bill to suspend temporarily the duty on 1,3,5-Triazine-2,4-diamine, N-[(1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1-yl]-6-(1-fluoroethyl) (INDAZIFLAM) whether or not mixed with application adjuvants (HTSUS 2933.69.60; CAS 950782-86-2) ) (INDAZIFLAM)
A bill to extend the temporary suspension of duty on Phosphorus Thiochloride (PSCL3)
A bill to extend the temporary suspension of duty on Desmedipham in bulk or mixtures
A bill to extend the temporary suspension of duty on Phenmedipham
Miscellaneous Tariff Bill
Bayer CropScience had previously requested several chemicals to be included in the Miscellaneous Tariff Bill that are no longer part of the companys request. Bayer CropScience has asked that the following bills or chemicals not be included in the Miscellaneous Tariff Bill on the companys behalf. (TAR)
A bill to suspend temporarily the duty on Thionyl chloride
A bill to suspend the temporary duty suspension on Sodium Methylate Solution
A bill to suspend temporarily the duty on Spiroxamine
A bill to extend the temporary duty suspension on NORTRON SC
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 598 American Recovery and Reinvestment Act of 2009, a bill to expande the research and development tax credit for energy research expesenses related to fuel cells, battery technology, renewable energy and carbon capture and sequestration; (All provisions related to research and development.)
HR 2438 to amend the Internal Revenue Code of 1986 to provide temporary bonus research credit for energy related research; (All
provisions pertaining to the enhanced credit for energy research.)
S. 1631 Customs Reauthorization Act; (Stragety and input on the bill for Senate Finance staff.)
Protocol Number HP-1350 US france protocol to Income Tax Treaty; (Provisions relating to entire bill.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
|
Karen |
Niedermeyer |
Ms. |
|
|
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
S 1631 Customs Reauthorization Act; (Strategy and input on the bill for Senate Finance staff.)
U.S. Korea Free Trade Agreement (Provisions relating to entire bill.)
U.S. Colombia Free Trade Agreement; (Provisions relating to entire bill.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Karen |
Niedermeyer |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
HR 4159 A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to require local educational agencies and schools to implement integrated pest management programs to minimize the use of pesticides in schools and to provide parents, guardians, and employees with notice of the use of pesticides in schools, and for other purposes; (Provisions relating to pesticides.)
S. 787 A bill to amend the Federal Water Pollution Control Act to clarity the jurisdition of the United States over waters of the United States; (Provisions related to agriculture activities and the section changing the definition of U.S. Waters.)
HR 2454 To create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions related to agriculture activities, allowances/offsets and credits and the "cap and trade" system for agriculture.)
S 1733 A bill to create clean energy jobs, promote energy jobs, promote energy independence, reduce global warming pollution, and transition to a clean energy economy; (All provisions related to agriculture, allowances and offsets.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
HR 21 to establish a national policy for our oceans, to strengthen the National Oceanic and Atmospheric Administration, to establish a national and regional ocean governance structure, and for other purposes; (Provisions related to regulations/changes to upstream activities that could affect agriculture.)
Regulatory Biotech Issues (Provisions in proposed regulations regarding the approval of biotech traits and all other issues related to biotech regulations, in particular APHIS Part 340.)
ESA Issues (NMFS biological opinions -- Discussions on National Marine Fisheries biological Opinions that were recently released and their potential affects on agriculture.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HR 2997/S 1406 Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2010, and for other purposes; (all provisions related to agriculture research funding, funding of conservation programs and funding of USDA agencies indcluding APHIS and FAS.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Miscellaneous Tariff Bill (No number yet): To seek introduction of bills to provide duty suspension or duty reduction on chemicals as listed below, similar to bill introduced in the 110th congress:
A bill to extend the temporary suspension of duty on o-Acetylsalicylic acid (Aspirin).
A bill to extend the temporary suspension of duty on D-Mannose.
A bill to extend the suspension of duty on Mixtures of Methyl o-toluenesulonate and methyl p-toluenesulfonate (TSME).
A bill to extend the suspension of duty on Trimethylopropane tris(3-aziridinylpropanoate) (Xama 2)
A bill to extend the suspension of duty on Polyfunctional aziridine (Xama 7).
A bill to extend the suspension of duty on 1,3-Diisocyanatomethylbenzene, polymer with 1,6-diisocyanatohexane (Desmondur VP HL).
A bill to extend the suspension of duty on A linear aromatic polyurethane prepolymer based on toluene diisocyanate. (Desmondur E 14
A bill to extend the suspension of duty on Poly(toluene diisocyanate) (Desmondur IL BA).
A bill to extend the suspension of duty on Polyisocyanate cross linking agent products containing triphenylmethane triisocyanate in solvents, (Desmondur R-E).
A bill to extend suspension of duty on Mixtures of tris(4-isocyanatophenyl)thiophosphate) in solvents, (Desmondur RF-E).
A bill to extend the suspension of duty on hexane 1,6, diisocynato-, homopolymer, 3,5, dimethyl-1H-pyrazole-blocked solvents.( Desmodur VP LS 2253)
A bill to extend the suspension of duty on Copolymer of methyl ethyl ketoximine and toluene diisocyanate (Desmondur BL XP).
A bill to extend the suspension of duty on 2-Oxepanone polymer with 1,4-butanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-ethyl-1-hexanol-blocked (Crelan).
A bill to suspend temporarily the duty on Propoxur (Sedran Technical).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
|
Karen |
Niedermeyer |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
HR 2868 Chemical Security Act of 2009, to amend the Homeland Security Act of 2002 to enhance security at chemical plants; (All provisions pertaining to inherently safer technology, citizen suits and information disclosure.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |